5AM Ventures
Venture capitalBoston · Seed–Late Stage · 40 people tracked
Investment thesis
5AM invests in diversified advanced life science technologies across biopharmaceutical, drug delivery, and research instrument sectors. The firm focuses on innovative platform technologies, corporate spin-offs, and products with shorter development cycles, with investments spanning multiple therapeutic areas within healthcare.
Source: firm website, verified Jul 21, 2026.
Team · 40 people
from the firm's websiteWhat they invest in
from 4 of 89 portfolio companiesBiotech ×3AI & Machine Learning ×2Deep Tech ×2Digital Health ×1Enterprise Software ×1Healthtech ×1Medical Devices ×1SaaS ×1
HQs:United States×5
Investments · showing 60 of 89
founders shown can be your intro pathLifordi Immunotherapeutics develops treatments for immunology and rare diseases through discovery, clinical development, and commercialization. The company serves patients with immunological disorders and rare genetic conditions.
BiotechDeep TechHealthtech
Arthur O. Tzianabos, Ph.D.(President and CEO)Naina Bhasin, Ph.D.(Chief Business Officer)
Precede Biosciences develops a blood-based diagnostic platform that profiles gene expression from cell-free DNA to reveal disease biology at the transcriptional level for drug developers and clinical trials. The platform enables non-invasive patient selection and longitudinal tracking of disease mechanisms in oncology and other therapeutic areas.
AI & Machine LearningBiotechDigital HealthBoston, US
Rehan Verjee(Co-Founder, Chief Executive Officer, Board Director)Sylvan Baca(Co-Founder; Assistant Professor of Medicine, Dana-Farber Cancer Institute)Toni Choueiri(Co-Founder; Director, Lank Center for GU Oncology, Dana-Farber Cancer Institute)Matthew Freedman(Co-Founder; Professor of Medicine, Dana-Farber Cancer Institute)
Bioz provides AI-powered widgets for suppliers that display scientific publication data to build trust and improve sales conversion.
AI & Machine LearningEnterprise SoftwareSaaS
nChroma Bio develops in vivo targeted delivery and genetic engineering technologies for genetic medicine applications. The company works with academic founders and institutional investors focused on advancing gene therapy treatments.
BiotechDeep TechMedical Devices
Luke Gilbert, PhDKeith Joung, MD, PhDDavid Liu, PhDAngelo Lombardo, PhD
Board seats · per SEC filings · 4
what is this? ⓘ$6.6M raise · filed Apr 2024 · via Kush M. Parmar, Paula M. Soteropoulos
$129M raise · filed May 2023 · via Kush M Parmar, Paula Soteropoulos
$116.2M raise · filed Apr 2021 · via Kush M. Parmar
$34.4M raise · filed Apr 2021 · via Joseph J. Victor
Inferred from directors named on each company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does 5AM Ventures invest at?
- 5AM Ventures invests at the Seed, Series A, Growth, Late Stage stages.
- What sectors does 5AM Ventures focus on?
- 5AM Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is 5AM Ventures located?
- 5AM Ventures is headquartered in Boston, US.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
USVP is a venture capital firm with over 40 years of history across four generations of technology investing. The firm has deployed $4.7B across 542 companies, generating 97 IPOs, and combines 150 years of combined operating experience with deep expertise in enterprise software, security, consumer technology, and healthcare.
A venture capital firm that supports founders developing transformative solutions across interconnected systems, with a particular focus on leveraging artificial intelligence and related technologies to advance health and human flourishing.